Xavier Thank you for your response and appreciate your DD I'm going to scroll thru some of your earlier posts and may comment if you don't mind. I saw that you had commented on MDCO ...which I owned thru to buyout ( I'm on Repatha ) and have a small position in AMRN as I'm also on Vascepa ...with Crestor ( statin ) .
The AMRN board is very active with 2 major pending events ...the EU market decision apparently due in Q3 ( GIA, partner or sell ) and a major binary event with the patent trial appeal decision due roughly around EOY.
My biggest position is in CCXI ...which I've held over a year . My wife is a Renal PA and has patients on steroids ( which they hate and has limited long term use ) .CCXI's drug Avacopan will replace steroids in at least these CKD patients ...Co is on track to file its NDA mid year as well as report results from other trials later which fortunately weren't derailed by Covid. If you see any red flags for CCXI ...please advise thx Kiwi
News 
Market Data 
Discover 
AI
